<ARTICLE> 5
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                         DEC-31-1998
<PERIOD-START>                            JAN-01-1998
<PERIOD-END>                              SEP-30-1998
<CASH>                                      1,543,501 
<SECURITIES>                                   72,940         
<RECEIVABLES>                               1,858,034
<ALLOWANCES>                                   61,357
<INVENTORY>                                 1,028,456
<CURRENT-ASSETS>                            5,329,856 
<PP&E>                                      7,162,996
<DEPRECIATION>                              3,117,402
<TOTAL-ASSETS>                             12,581,264
<CURRENT-LIABILITIES>                       4,007,853
<BONDS>                                     2,268,891
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                      686,242
<OTHER-SE>                                  3,822,757
<TOTAL-LIABILITY-AND-EQUITY>               12,581,264
<SALES>                                     6,301,629 
<TOTAL-REVENUES>                            7,183,051
<CGS>                                       1,141,415         
<TOTAL-COSTS>                               1,895,511 
<OTHER-EXPENSES>                            3,253,159<F1>
<LOSS-PROVISION>                                    0<F2>
<INTEREST-EXPENSE>                            137,399
<INCOME-PRETAX>                             1,974,839
<INCOME-TAX>                                  437,060
<INCOME-CONTINUING>                         1,537,779
<DISCONTINUED>                                      0 
<EXTRAORDINARY>                               (7,249)
<CHANGES>                                           0 
<NET-INCOME>                                1,530,529
<EPS-PRIMARY>                                    1.39
<EPS-DILUTED>                                    1.36

<FN>
<F1> Amounts include research and development, selling and general and 
     administrative expenses.

<F2> The information called for is not given as the balances are not 
     individually significant.
</FN>